𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness of anastrozole compared to tamoxifen in hormone receptor–positive early breast cancer. Analysis based on the ATAC trial

✍ Scribed by K. MOEREMANS; L. ANNEMANS

Book ID
109085912
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
67 KB
Volume
16
Category
Article
ISSN
1048-891X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of anastrozole versus tamoxif
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer : The pre-operative “Arimidex” compared to Tamoxifen (PROACT) trial
✍ Luigi Cataliotti; Aman U. Buzdar; Shinzaburo Noguchi; Jose Bines; Yuichi Takatsu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract ## BACKGROUND The Pre‐Operative “Arimidex” Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative treatment of postmenopausal women with large, operable (T2/3, N0‐2, M0), or potentially operable (T4b, N0‐2, M0) br